Page last updated: 2024-11-05

ticlopidine and Mesenteric Vascular Occlusion

ticlopidine has been researched along with Mesenteric Vascular Occlusion in 2 studies

Ticlopidine: An effective inhibitor of platelet aggregation commonly used in the placement of STENTS in CORONARY ARTERIES.
ticlopidine : A thienopyridine that is 4,5,6,7-tetrahydrothieno[3,2-c]pyridine in which the hydrogen attached to the nitrogen is replaced by an o-chlorobenzyl group.

Mesenteric Vascular Occlusion: Obstruction of the flow in the SPLANCHNIC CIRCULATION by ATHEROSCLEROSIS; EMBOLISM; THROMBOSIS; STENOSIS; TRAUMA; and compression or intrinsic pressure from adjacent tumors. Rare causes are drugs, intestinal parasites, and vascular immunoinflammatory diseases such as PERIARTERITIS NODOSA and THROMBOANGIITIS OBLITERANS. (From Juergens et al., Peripheral Vascular Diseases, 5th ed, pp295-6)

Research Excerpts

ExcerptRelevanceReference
"Treatment with aspirin inhibited spontaneous platelet aggregation but had little effect on the activated platelet profile."1.29Platelet activation and thrombosis: studies in a patient with essential thrombocythemia. ( Bihour, C; Nurden, AT; Nurden, P; Raymond, JM; Smith, M, 1996)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19901 (50.00)18.7374
1990's1 (50.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Weichert, W1
Pauliks, V1
Breddin, HK1
Nurden, P1
Bihour, C1
Smith, M1
Raymond, JM1
Nurden, AT1

Other Studies

2 other studies available for ticlopidine and Mesenteric Vascular Occlusion

ArticleYear
Laser-induced thrombi in rat mesenteric vessels and antithrombotic drugs.
    Haemostasis, 1983, Volume: 13, Issue:1

    Topics: Animals; Aspirin; Blood Platelets; Dipyridamole; Disease Models, Animal; Fibrinolytic Agents; Hepari

1983
Platelet activation and thrombosis: studies in a patient with essential thrombocythemia.
    American journal of hematology, 1996, Volume: 51, Issue:1

    Topics: Adenosine Diphosphate; Adult; Antibodies, Monoclonal; Aspirin; Blood Platelets; Disease Susceptibili

1996